Abstract
This paper presents a preliminary analysis of the role of business support agencies in medical device value chain (MDVC) development. It takes the concept of local ‘business support mechanisms’ (BSM) beyond the boundaries of institutional theories and policy constructs to the operational level in the medical device value chain. Companies’ requirements are mapped against the business support provisions across the MDVC. This mapping highlights the mismatch of business support provision to industry requirements at different stages of the MDVC. The evidence shows that these misalignments stem from a complex BSM role configuration and an inability to address industry requirements, particularly in the medical device industry, which has unique needs. It is suggested that the concept of roles helps to find a better match between local BSM and the requirements of the MDVC. The value chain development roles played by Business Support Agencies (BSAs) are identified as follows: IP generators, Resource mobilisers, Policy formulators and implementers, Networking agents, and Information mediators. This paper explores the roles of the BSAs in addressing the MDVC requirements. Eight case studies are examined, offering new insights into the roles of BSAs, as well as their attributes and influential factors.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
The definition of the industry and classification of products in the medical device sector may vary from country to country as it is influenced by the specific country’s healthcare medical device regulation acts (USITC 2007). According to the EC’s, Medical Device Guideline Document (1994), medical devices are defined as products that are used for the propose of prevention, diagnosis, and treatment of diseases and injuries, and the correction of physical deformities of the body.
References
Bennett, R. (2003). Business link: Use, satisfaction and the influence of local governance regime. Policy Studies, 24(4), 163–186.
Best, M. (2006). Massachusetts medical devices: Leveraging the region’s capabilities. MassBenchmarks, 8(1), 14–25.
BIS. (2009). Strengths and opportunities: Landscape of the medical technology, medical biotechnology and industrial biotechnology enterprises in the UK. London: Department of Business, Innovation and Skills.
Burns, R. L. (2002). The health care value chain: Producers, purchasers, and providers. New York: Wiley.
Christopher, M., Peck, H., & Towill, D. (2006). A taxonomy for selecting global supply chain strategy. International Journal of Logistics Management, 17(2), 277–287.
Clements, I. (2008, April 10). Japan medical device market overview. International trade administration. U.S. Department of Commerce.
CST. (2007). Strategic decision making for technology policy. London: Council for Science and Technology.
de Vet, M. J., & Scott, A. J. (1992). The Southern Californian medical device industry: Innovation, new firm formation, and location. Research Policy, 21, 145–161.
Fennelly, D., & Cormican, K. (2004). Value chain migration from production to product centered operations: An analysis of the Irish medical device industry. Technovation, 26, 86–94.
Gemmell, S. (2009). Supporting business: A strategy for business support in the East Midlands. East Midlands: EMDA.
Harland, C. M. (1996). Supply chain management: Relationships, chains and networks. British Journal of Management, 7(Special Issue), S63–S80.
Hines, P., & Rich, N. (1997). The seven value stream mapping tools. International Journal of Operations, 17(1), 46–64.
Humphrey, J., & Schmitz, H. (1996). Governance and upgrading: Linking industrial cluster and global value chain research. IDS Working Paper 120.
Humphrey, J., & Schmitz, H. (2000). Governance and upgrading: Linking industrial cluster and global value chain research. Institute of Development Studies. Sussex: IDS Working Paper 120.
Japan MDC, L. (2007). Medical device market Japan 2007. Tokyo: Swiss Business Hub Japan.
Kaplan, A. V., Baim, D. S., Smith, J. J., Feigal, D. A., Simons, M., Jefferys, D., et al. (2004). Medical device development: From prototype to regulatory approval. Journal of the American Heart Association, 109, 3068–3072.
Kaufmann, A., & Wagner, P. (2005). EU regional policy and the stimulation of innovation: The role of the European regional development fund in the objective 1 region Burgenland. European Planning Studies, 13(4), 581–599.
Knight, L., & Harland, C. (2005). Managing supply network: Organisational roles in network management. European Management Journal, 23(3), 281–292.
Lambert, D. M., & Cooper, M. C. (2000). Issues in supply chain management. Industrial Marketing Management, 29, 65–83.
Livesey, F. (2006). Defining high value manufacturing. Cambridge: Institute for Manufacturing.
Matos, I. (2005). Medical technology in Germany leading Europe: Strength and opportunities. Berlin: Invest in Germany GmBH.
McKone-Sweet, K. E., Hamilton, P., & Willis, S. B. (2005). The ailing healthcare supply chain: A prescription for change. The Journal of Supply Chain Management, 41(1), 4–17.
Nadvi, K. (2008). Global standards, global governance and the organisation of global value chains. Journal of Economic Geography, 8(3), 323–343.
Narrod, C., Roy, D., Okello, J., Avendano, B., Rick, K., & Thorat, A. (2009). Public-private partnerships and collective action in high value fruit and vegetable supply chains. Food Policy, 34, 8–15.
Navdi, K., & Halder, G. (2005). Local clusters in global value chains: Exploring dynamic linkages between Germany and Pakistan. Enterpreneurship & Regional Development, 17(5), 339–363.
Pfeiffer, M. (2009). The medical technology industry in Germany: Industry overview. Berlin: Germany Trade and Invest.
Porter, M. E. (1990). The competitive advantage of nations. New York: Free Press.
Porter, J. (1998). The role of high technology in a regional economy. In U. S. Bititci & A. S. Carrie (Eds.), Strategic management of the manufacturing value chain (pp. 3–10). Scotland: International Conference of the Manufacturing Value chain.
Quotec. (2009). Commercialising medical devices: A guide for UK based small companies. Bucks: Quotec Limited.
Rana, D., Srai, J. S., & Gregory, M. (2009). An exploration of regional government support to facilitate the supply network configuration of the medical device industry. Implementation-realizing operations management knowledge. Goteborg: 16th international EurOMA conference.
Rochford, L., & Rudelius, W. (1997). New product development process: Stages and successes in the medical products industry. Industrial Marketing Management, 26, 67–84.
Sheffi, Y. (2001). Supply chain management under the threat of international terrorism. The International Journal of Logistics Management, 12(2), 1–11.
Solvell, O., Lindqvist, G., & Ketels, C. (2003). The cluster initiative greenbook. Stockholm: Ivory Tower.
Sturgeon, T., Biesebroeck, J. V., & Gereffi, G. (2008). Value chains, networks and clusters: Reframing the global automotive industry. Journal of Economic Geography, 8(3), 297–321.
Tan, K. C. (2001). A framework of supply chain management literature. European Journal of Purchasing and Supply Chain Management, 7, 39–48.
Todeva, E. (2008). Health technology cluster in the greater south east. SEEDA, EEDA and LDA. London: SETHA.
UNIDO. (2009). Value chain diagnostics for industrial development. Vienna: United Nations Industrial Development Organisation.
USITC. (2007). Medical devices and equipment: Competitive conditions affecting U.S. trade in Japan and other principal foreign markets. Washington, DC: United States International Trade Commissions.
WHO. (2003). Medical device regulations: Global overview and guiding principles. Geneva: World Health Organisation.
WHO. (2010). Medical devices: Managing the mismatch. An outcome of the priority medical device project. Geneva: World Health Organisation.
Williams, D. J., Hourd, P., & Chandra, A. (2008). Enhancing the competitiveness of health technology SMEs. Loughborough University, Wolfson School of Mechanical and Manufacturing Engineering. Loughborough: Healtcare Engineering Group.
Wren, C., & Storey, D. J. (2002). Evaluating the effect of the soft business support upon small firm performance. Oxford Economic Papers, 54, 334–365.
Yin, R. K. (2005). Case study research: Design and methods (3rd ed., Vol. 5). Thousand Oaks: Sage Publications.
Acknowledgments
The authors are grateful to Dr. Sally Church for her valuable comments and for proofreading this paper.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Rana, D., Gregory, M. (2012). Exploring the Role of Business Support Agencies in Value Chain Management of the Medical Device Industry. In: Jodlbauer, H., Olhager, J., Schonberger, R. (eds) Modelling Value. Contributions to Management Science. Physica-Verlag HD. https://doi.org/10.1007/978-3-7908-2747-7_20
Download citation
DOI: https://doi.org/10.1007/978-3-7908-2747-7_20
Published:
Publisher Name: Physica-Verlag HD
Print ISBN: 978-3-7908-2746-0
Online ISBN: 978-3-7908-2747-7
eBook Packages: Business and EconomicsBusiness and Management (R0)